Literature DB >> 28468953

Prevalence of Tibial Artery and Pedal Arch Patency by Angiography in Patients With Critical Limb Ischemia and Noncompressible Ankle Brachial Index.

Mandeep Singh Randhawa1, Grant W Reed1, Kevin Grafmiller1, Heather L Gornik1, Mehdi H Shishehbor2.   

Abstract

BACKGROUND: Approximately 20% of patients undergoing ankle brachial index testing for critical limb ischemia have noncompressible vessels because of tibial artery calcification. This represents a clinical challenge in determining tibial artery patency. We sought to identify the prevalence of tibial artery and pedal arch patency by angiography in these patients. METHODS AND
RESULTS: One hundred twenty-five limbs (of 89 patients) with critical limb ischemia and ankle brachial index ≥1.4 who underwent lower extremity angiograms within 1 year were included. Reviewers of angiography were blinded to results of physiological testing. Tibial artery vessels were classified as completely occluded, significantly stenosed (≥50%), or patent (<50% stenosis). The sensitivity of toe brachial index and pulse volume recording to predict tibial artery disease was also determined. Of 125 limbs with noncompressible ankle brachial index, 72 (57.6%) anterior tibial and 80 (64%) posterior tibial arteries were occluded. Another 23 (18.4%) anterior tibial and 13 (10.4%) posterior tibial arteries had ≥50% stenosis. Pulse volume recording was moderate to severely dampened in 54 of 119 (45.4%) limbs. Toe brachial index <0.7 was found in 75 of 83 (90.4%) limbs. Moderate to severe pulse volume recording dampening was 43.6% sensitive, whereas toe brachial index <0.7 was 89.7% sensitive in diagnosing occluded or significantly stenotic tibial artery disease. The pedal arch was absent or incomplete in 86 of 103 (83.5%) limbs.
CONCLUSIONS: Among patients with critical limb ischemia and noncompressible ankle brachial index results, the prevalence of occlusive tibial and pedal arch disease is very high. Toe brachial index <0.7 is more sensitive in diagnosing occluded and significantly stenotic tibial artery disease in these patients compared with ankle pulse volume recording.
© 2017 American Heart Association, Inc.

Entities:  

Keywords:  angiography; ankle brachial index; foot; peripheral artery disease; tibial arteries

Mesh:

Year:  2017        PMID: 28468953     DOI: 10.1161/CIRCINTERVENTIONS.116.004605

Source DB:  PubMed          Journal:  Circ Cardiovasc Interv        ISSN: 1941-7640            Impact factor:   6.546


  6 in total

Review 1.  Noninvasive Arterial Testing: What and When to Use.

Authors:  Derek Mittleider
Journal:  Semin Intervent Radiol       Date:  2019-02-05       Impact factor: 1.513

2.  [Interpretation of 2019 International Working Group on Diabetic Foot guidelines on the prevention and management of diabetic foot disease].

Authors:  Lei Gao; Jiangning Wang; Yefeng Yin
Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi       Date:  2020-01-15

3.  Perfusion Assessment in Critical Limb Ischemia: Principles for Understanding and the Development of Evidence and Evaluation of Devices: A Scientific Statement From the American Heart Association.

Authors:  Sanjay Misra; Mehdi H Shishehbor; Edwin A Takahashi; Herbert D Aronow; Luke P Brewster; Matthew C Bunte; Esther S H Kim; Jonathan R Lindner; Kathleen Rich
Journal:  Circulation       Date:  2019-08-12       Impact factor: 29.690

4.  Doppler Ultrasonography Derived Maximal Systolic Acceleration: Value Determination With Artificially Induced Stenosis.

Authors:  Jeroen J W M Brouwers; Louk P van Doorn; Laurie Pronk; Rob C van Wissen; Hein Putter; Abbey Schepers; Jaap F Hamming
Journal:  Vasc Endovascular Surg       Date:  2022-03-02       Impact factor: 1.046

5.  Angiosome~From the Standpoint of Bypass Surgery.

Authors:  Juno Deguchi
Journal:  Ann Vasc Dis       Date:  2020-06-25

6.  SCAI/ACR/APMA/SCVS/SIR/SVM/SVS/VESS Position Statement on Competencies for Endovascular Specialists Providing CLTI Care.

Authors:  Beau M Hawkins; Jun Li; Luke R Wilkins; Teresa L Carman; Amy B Reed; David G Armstrong; Philip Goodney; Christopher J White; Aaron Fischman; Marc L Schermerhorn; Dmitriy N Feldman; Sahil A Parikh; Mehdi H Shishehbor
Journal:  Vasc Med       Date:  2022-04-25       Impact factor: 4.739

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.